Explore how AI-driven approaches enhance high-throughput screening by optimizing DNA-encoded libraries (DEL) for rapid identification of potential drug candidates.
Learn how AI algorithms accelerate the analysis of complex screening data, enabling more efficient lead discovery and targeting of molecular interactions.
Speaker(s):
Hans Bitter
Head, Computational Sciences
Takeda
Christos Nicolaou
Senior Director, Digital Chemistry and Design
Novo Nordisk
Jeff Messer
Director Analytics
GSK
Time:
11:45 AM - 12:15 PM
Agenda Track No.:
Track 2
Session Type:
General Session (Presentation)